News about Drug Discovery & Development

Lupin Launches World's First Fixed-dose Triple Combination Drug

Lupin Vilfuro-G® is the only FDC that uniquely combines Vilanterol, Fluticasone Furoate and Glycopyrronium Bromide, for the long-term management and treatment of moderate to severe COPD.

Drug Discovery & Development | 27/11/2023 | By Manvi |  797

Lupin Gets Approval from US FDA for Pitavastatin Tablets

Pitavastatin Tablets are indicated as an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in Adults with primary hyperlipidemia, Adults and pediatric patients aged 8 years and older with heterozygous familial hypercholesterolemia (HeFH).

Drug Discovery & Development | 22/11/2023 | By Manvi |  512

Qubit Pharmaceuticals Announces Euro 4.5 Mn Investment in New Drug Discovery Platform

The initiative is supported by Bpifrance with a total investment of €2 million via the Investissements d'Avenir and France 2030 programs.

Drug Discovery & Development | 20/11/2023 | By Manvi |  723

Venus Remedies Granted Market Authorization for Bleomycin 15,000 IU in UK

This remarkable milestone not only expands the pharma giant's global presence but also underscores its commitment to advancing cancer care with innovative solutions.

Drug Discovery & Development | 30/10/2023 | By Manvi |  784

Sun Pharma Recalls 144 Bottles of Anti-Depression Drug from US Market

Sun Pharmaceutical Industries Inc has recalled 144 bottles of a generic anti-depression medicine from the US market due to a manufacturing issue, according to the U.S. Food and Drug Administration (FDA).

Drug Discovery & Development | 23/10/2023 | By Manvi |  573

Glenmark Pharmaceuticals Gets ANDA Approval for Apremilast Tablets, 10 mg, 20 mg and 30 mg

According to IQVIATM sales data for the 12-month period ending August 2023, the Otezla® Tablets, 10 mg, 20 mg, and 30 mg market2 achieved annual sales of approximately USD 3.7 billion.

Drug Discovery & Development | 18/10/2023 | By Manvi |  862

Venus Remedies Gets Marketing Approval for Six Chemotherapy Drugs from Philippines

Venus Remedies has secured marketing authorisation for bortezomib, cisplatin, doxorubicin, docetaxel, flurouracil and paclitaxel from the Philippines, thus making it a significant market for the company from the ASEAN region.

Drug Discovery & Development | 18/10/2023 | By Manvi |  686

DST Grants INR 13.69 Cr to GITAM for Drug Discovery Centre

The grant, conferred through the Promotion of University Research and Scientific Excellence (PURSE) program, will support the procurement of new equipment, research costs, manpower, conduct of workshops/summer schools etc.

Drug Discovery & Development | 16/10/2023 | By Manvi |  878

Shilpa Medicare Launches ORAAL for the Treatment of Oral Mucositis

ORAAL, a substantial advancement in Oral Mucositis management, has been accepted and approved by the Indian Dental Association.

Drug Discovery & Development | 16/10/2023 | By Manvi |  1342

Fujitsu and RIKEN Develop AI Drug Discovery Technology Utilizing Generative AI to Predict Structural Changes in Proteins

Fujitsu Limited and the HPC- and AI-driven Drug Development Platform Division of the RIKEN Center for Computational Science announced that they have developed an AI drug discovery technology that can predict structural changes of proteins from electron microscope images as a 3D density map in wide range by utilizing generative AI in January 2023.

Drug Discovery & Development | 11/10/2023 | By Manvi |  758